{"authors": [["Kobalava", "Z D", "ZD", "Federal State Autonomous Educational Institution of Higher Education, \"Peoples' Friendship University of Russia\"."], ["Villevalde", "S V", "SV", "Federal State Autonomous Educational Institution of Higher Education, \"Peoples' Friendship University of Russia\"."], ["Kulakov", "V V", "VV", "Federal State Autonomous Educational Institution of Higher Education, \"Peoples' Friendship University of Russia\"."]], "text": "To study effects of a fixed azilsartan medoxomil/chlorthalidone combination (Edarbi Clo) on clinical, ambulatory and central blood pressure (BP) in patients with uncontrolled arterial hypertension (AH)).Patients (n=25) with uncontrolled AH were given fixed azilsartan medoxomil/chlorthalidone combination (40 / 12.5 mg / day) for 4 weeks. After 4 weeks, in patients who did not achieve target BP levels the dose was increased up to 40 / 25 mg / day. Duration of the study was 12 weeks.After 12 weeks of treatment 88 % of patients achieved target clinical BP (.", "id": "29276912", "date": null, "title": "[Antihypertensive Efficacy of Fixed Combination Azilsartan Medoxomil / Chlorthalidone in Patients With Uncontrolled Arterial Hypertension].", "doi": null, "journal": ["Kardiologiia", "Kardiologiia"]}